Lancet Article Highlights Hope in the Tuberculosis Drug Development Pipeline
According to a paper published today in The Lancet, there is unprecedented progress in the development of the global tuberculosis
According to a paper published today in The Lancet, there is unprecedented progress in the development of the global tuberculosis
New York and Bangalore, India, May 3, 2010 – The Global Alliance for TB Drug Development (TB Alliance) and AstraZeneca
Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership (PDP) accelerating the discovery and development of
The Global Alliance for TB Drug Development (TB Alliance) today announced the appointment of Dr. Carlos Morel to its Board
New York, NY– January 11, 2010 The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership
The TB Alliance recently announced the appointment of Marshall Burke, Ph.D. as the organization’s Senior Vice President, External Affairs. Dr.
The Institute of Materia Medica (IMM), a member of the Chinese Academy of Sciences, was recently awarded a grant from
[Seattle, WA] A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance) a not-for-profit, product development
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
Global Health Technologies Coalition receives funding to encourage new health solutions for the developing world Washington, DC, USA, May 15,